24P Is molecular characterization useful for targeted therapy orientation in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) included in early phase clinical trials?
| Autor: | Michot, J-M., Camara-Clayette, V., Quivoron, C., Danu, A., Lazarovici, J., Ghez, D., Rossignol, J., Baldini, C., Martin Romano, P., Sarkozy, C., Varga, A., Cotteret, S., Dartigues, P., Massard, C., Ribrag, V. |
|---|---|
| Zdroj: | In Annals of Oncology October 2020 31 Supplement 5:S1224-S1224 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|